186 related articles for article (PubMed ID: 29489437)
1. Antibody Responses to a Quadrivalent Hepatitis C Viral-Like Particle Vaccine Adjuvanted with Toll-Like Receptor 2 Agonists.
Christiansen D; Earnest-Silveira L; Chua B; Boo I; Drummer HE; Grubor-Bauk B; Gowans EJ; Jackson DC; Torresi J
Viral Immunol; 2018 May; 31(4):338-343. PubMed ID: 29489437
[TBL] [Abstract][Full Text] [Related]
2. Immunological responses following administration of a genotype 1a/1b/2/3a quadrivalent HCV VLP vaccine.
Christiansen D; Earnest-Silveira L; Chua B; Meuleman P; Boo I; Grubor-Bauk B; Jackson DC; Keck ZY; Foung SKH; Drummer HE; Gowans EJ; Torresi J
Sci Rep; 2018 Apr; 8(1):6483. PubMed ID: 29691437
[TBL] [Abstract][Full Text] [Related]
3. Immune responses against hepatitis C virus genotype 3a virus-like particles in mice: A novel VLP prime-adenovirus boost strategy.
Kumar A; Das S; Mullick R; Lahiri P; Tatineni R; Goswami D; Bhat P; Torresi J; Gowans EJ; Karande AA; Das S
Vaccine; 2016 Feb; 34(8):1115-25. PubMed ID: 26700891
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C VLPs delivered to dendritic cells by a TLR2 targeting lipopeptide results in enhanced antibody and cell-mediated responses.
Chua BY; Johnson D; Tan A; Earnest-Silveira L; Sekiya T; Chin R; Torresi J; Jackson DC
PLoS One; 2012; 7(10):e47492. PubMed ID: 23091628
[TBL] [Abstract][Full Text] [Related]
5. Pre-clinical evaluation of a quadrivalent HCV VLP vaccine in pigs following microneedle delivery.
Christiansen D; Earnest-Silveira L; Grubor-Bauk B; Wijesundara DK; Boo I; Ramsland PA; Vincan E; Drummer HE; Gowans EJ; Torresi J
Sci Rep; 2019 Jun; 9(1):9251. PubMed ID: 31239471
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a hepatitis C virus-like particle vaccine produced in a human hepatocyte-derived cell line.
Earnest-Silveira L; Chua B; Chin R; Christiansen D; Johnson D; Herrmann S; Ralph SA; Vercauteren K; Mesalam A; Meuleman P; Das S; Boo I; Drummer H; Bock CT; Gowans EJ; Jackson DC; Torresi J
J Gen Virol; 2016 Aug; 97(8):1865-1876. PubMed ID: 27147296
[TBL] [Abstract][Full Text] [Related]
7. Recombinant retrovirus-derived virus-like particle-based vaccines induce hepatitis C virus-specific cellular and neutralizing immune responses in mice.
Huret C; Desjardins D; Miyalou M; Levacher B; Amadoudji Zin M; Bonduelle O; Combadière B; Dalba C; Klatzmann D; Bellier B
Vaccine; 2013 Mar; 31(11):1540-7. PubMed ID: 22634300
[TBL] [Abstract][Full Text] [Related]
8. Combined adenovirus vector and hepatitis C virus envelope protein prime-boost regimen elicits T cell and neutralizing antibody immune responses.
Chmielewska AM; Naddeo M; Capone S; Ammendola V; Hu K; Meredith L; Verhoye L; Rychlowska M; Rappuoli R; Ulmer JB; Colloca S; Nicosia A; Cortese R; Leroux-Roels G; Balfe P; Bienkowska-Szewczyk K; Meuleman P; McKeating JA; Folgori A
J Virol; 2014 May; 88(10):5502-10. PubMed ID: 24599994
[TBL] [Abstract][Full Text] [Related]
9. Neutralization effects of antibody elicited by chimeric HBV S antigen viral-like particles presenting HCV neutralization epitopes.
Wei S; Lei Y; Yang J; Wang X; Shu F; Wei X; Lin F; Li B; Cui Y; Zhang H; Wei S
Vaccine; 2018 Apr; 36(17):2273-2281. PubMed ID: 29576303
[TBL] [Abstract][Full Text] [Related]
10. Native Folding of a Recombinant gpE1/gpE2 Heterodimer Vaccine Antigen from a Precursor Protein Fused with Fc IgG.
Logan M; Law J; Wong JAJ; Hockman D; Landi A; Chen C; Crawford K; Kundu J; Baldwin L; Johnson J; Dahiya A; LaChance G; Marcotrigiano J; Law M; Foung S; Tyrrell L; Houghton M
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795422
[TBL] [Abstract][Full Text] [Related]
11. Role of the E2 Hypervariable Region (HVR1) in the Immunogenicity of a Recombinant Hepatitis C Virus Vaccine.
Law JLM; Logan M; Wong J; Kundu J; Hockman D; Landi A; Chen C; Crawford K; Wininger M; Johnson J; Mesa Prince C; Dudek E; Mehta N; Tyrrell DL; Houghton M
J Virol; 2018 Jun; 92(11):. PubMed ID: 29540595
[TBL] [Abstract][Full Text] [Related]
12. A Hepatitis C Virus DNA Vaccine Encoding a Secreted, Oligomerized Form of Envelope Proteins Is Highly Immunogenic and Elicits Neutralizing Antibodies in Vaccinated Mice.
Masavuli MG; Wijesundara DK; Underwood A; Christiansen D; Earnest-Silveira L; Bull R; Torresi J; Gowans EJ; Grubor-Bauk B
Front Immunol; 2019; 10():1145. PubMed ID: 31178869
[TBL] [Abstract][Full Text] [Related]
13. Keyhole Limpet Hemocyanin-Conjugated Peptides from Hepatitis C Virus Glycoproteins Elicit Neutralizing Antibodies in BALB/c Mice.
Deng K; Xu Z; Chen M; Liu X
J Immunol Res; 2021; 2021():3108157. PubMed ID: 33532506
[TBL] [Abstract][Full Text] [Related]
14. Immunization With a Subunit Hepatitis C Virus Vaccine Elicits Pan-Genotypic Neutralizing Antibodies and Intrahepatic T-Cell Responses in Nonhuman Primates.
Li D; Wang X; von Schaewen M; Tao W; Zhang Y; Heller B; Hrebikova G; Deng Q; Sun Q; Ploss A; Zhong J; Huang Z
J Infect Dis; 2017 Jun; 215(12):1824-1831. PubMed ID: 28398489
[TBL] [Abstract][Full Text] [Related]
15. Antibodies Targeting Novel Neutralizing Epitopes of Hepatitis C Virus Glycoprotein Preclude Genotype 2 Virus Infection.
Deng K; Liu R; Rao H; Jiang D; Wang J; Xie X; Wei L
PLoS One; 2015; 10(9):e0138756. PubMed ID: 26406225
[TBL] [Abstract][Full Text] [Related]
16. Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies.
Vietheer PT; Boo I; Drummer HE; Netter HJ
Antivir Ther; 2007; 12(4):477-87. PubMed ID: 17668556
[TBL] [Abstract][Full Text] [Related]
17. Oral immunization with attenuated Salmonella carrying a co-expression plasmid encoding the core and E2 proteins of hepatitis C virus capable of inducing cellular immune responses and neutralizing antibodies in mice.
Cao J; Chen Z; Ren Y; Luo Y; Cao M; Lu W; Zhao P; Qi Z
Vaccine; 2011 May; 29(20):3714-23. PubMed ID: 21396407
[TBL] [Abstract][Full Text] [Related]
18. Antibody Responses to Immunization With HCV Envelope Glycoproteins as a Baseline for B-Cell-Based Vaccine Development.
Chen F; Nagy K; Chavez D; Willis S; McBride R; Giang E; Honda A; Bukh J; Ordoukhanian P; Zhu J; Frey S; Lanford R; Law M
Gastroenterology; 2020 Mar; 158(4):1058-1071.e6. PubMed ID: 31809725
[TBL] [Abstract][Full Text] [Related]
19. N-glycosylation-mutated HCV envelope glycoprotein complex enhances antigen-presenting activity and cellular and neutralizing antibody responses.
Ren Y; Min YQ; Liu M; Chi L; Zhao P; Zhang XL
Biochim Biophys Acta; 2016 Aug; 1860(8):1764-75. PubMed ID: 26278021
[TBL] [Abstract][Full Text] [Related]
20. Novel adeno‑associated virus‑based genetic vaccines encoding hepatitis C virus E2 glycoprotein elicit humoral immune responses in mice.
Zhu F; Wang Y; Xu Z; Qu H; Zhang H; Niu L; Xue H; Jing D; He H
Mol Med Rep; 2019 Feb; 19(2):1016-1023. PubMed ID: 30569131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
